Pharmaxis, Mesoblast, CathRx, Fluorotechnics, Sonic, Avita, Biota [ + ]

Groundbreaking CSIRO research into how the deadly Hendra virus spreads promises to save the lives of both horses and humans in the future.

Concrete proof that Australia can clean up highly contaminated sites thoroughly, safely and economically is emerging from a new national program.

Pharmaxis, Cochlear, CSL, HeartWare, Sirtex, Progen [ + ]

Team Bufo may have found cane toad’s Achilles heel – meat ants [ + ]

Normal animals have one mitochondrial chromosome, but blood-sucking lice have 18 [ + ]

Progen, Cytopia, Avexa, Acrux, Biota, Cellestis [ + ]

Mesoblast raises $10 million from new and existing investors [ + ]

ChemGenex’ lead candidate kills cancer stem cells in animal model [ + ]

Viralytics granted patent in US for oncolytic echoviruses [ + ]

TGR BioSciences CSO Michael Crouch wins Advancing BioBusiness Award [ + ]

Biota’s partner Daiichi Sankyo applies for marketing licence, finishes Phase III enrolment [ + ]

Cochlear, CSL, Progen, Genera Biosystems, Peplin [ + ]

16 new fellows elected to Australian Academy of Science [ + ]

The 'What's Your Problem New Zealand?' competition gives New Zealand enterprises, big or small, the chance to win up to $1 million in research and development services from one of New Zealand’s leading technology partners.